Biotech unicorn Moderna files for IPO of up to $500M
November 09, 2018 at 16:01 PM EST
One of Massachusetts biotech's largest unicorns, Moderna Therapeutics, is planning to go public with an IPO close to $500 million, according to documents filed Friday.
